Publications found:
36,576
Sort by:
Cytomegalovirus Infection Treatment Market - 2024-2031
US$ 3,400.00
Cytomegalovirus Infection Treatment Marketis is growing with a CAGR of 6.70% during the forecast period 2026-2035. The Cytomegalovirus Infection Treatment Market emerges as a key focus in DataM Intell...
August 2024
61 pages
Langerhans Cell Histiocytosis Management Market - 2024-2031
US$ 3,400.00
Langerhans Cell Histiocytosis Management Market reached US$ 865.4 million in 2023 and is expected to reach US$ 1409.4 million by 2031, growing with a CAGR of 6.40% during the forecast period 2026-2031...
August 2024
66 pages
Europe Acute Schizophrenia Treatment Market - 2024-2031
US$ 2,499.00
Europe Acute Schizophrenia Treatment Market reached in and is expected to reach by , growing with a CAGR of 0.00% during the forecast period 2026-. The Europe Acute Schizophrenia Treatment Market emer...
August 2024
62 pages
Familial Lipoprotein Lipase Deficiency Market - 2024-2031
US$ 3,400.00
The Familial Lipoprotein Lipase Deficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
August 2024
64 pages
Angioimmunoblastic T-Cell Lymphoma Market - 2024-2031
US$ 3,400.00
The Angioimmunoblastic T-Cell Lymphoma Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
August 2024
60 pages
Pain Management Alternatives Market - 2024-2031
US$ 3,400.00
Pain Management Alternatives Market reached US$ 7.31 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 8.60% during the forecast period 2026-2031. The Pain Mana...
August 2024
54 pages
Renal Fanconi Syndrome Market - 2024-2031
US$ 3,400.00
Renal Fanconi Syndrome Market reached US$ 576.4 million in 2023 and is expected to reach US$ 767.5 million by 2031, growing with a CAGR of 3.70% during the forecast period 2026-2031. The Renal Fanconi...
August 2024
48 pages
Cancer CDK Inhibitors Market - 2024-2031
US$ 3,400.00
Cancer CDK Inhibitors Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Cancer CDK Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analy...
August 2024
47 pages
Metastatic Bone Pain Market - 2024-2031
US$ 3,400.00
Metastatic Bone Pain Market reached US$ 14.4 billion in 2023 and is expected to reach US$ 24 billion by 2031, growing with a CAGR of 6.70% during the forecast period 2026-2031. The Metastatic Bone Pai...
August 2024
46 pages
Von Hippel Lindau Disease Market - 2024-2031
US$ 3,400.00
Von Hippel Lindau Disease Market reached US$ 293.47 million in 2023 and is expected to reach US$ 501.24 million by 2031, growing with a CAGR of 6.92% during the forecast period 2026-2031. The Von Hipp...
August 2024
51 pages
Artemisinin Combination Therapy Market - 2024-2031
US$ 3,400.00
Artemisinin Combination Therapy Market reached US$ 547 million in 2023 and is expected to reach US$ 1,061 million by 2031, growing with a CAGR of 8.80% during the forecast period 2026-2031. The Artemi...
August 2024
57 pages
Genitourinary Drugs Market - 2024-2031
US$ 3,400.00
Genitourinary Drugs Market reached US$ 31,220.0 million in 2023 and is expected to reach US$ 35,518.8 million by 2031, growing with a CAGR of 1.60% during the forecast period 2026-2031. The Genitourin...
August 2024
45 pages
Global TROP2 Antibody Market & Clinical Trials Insight 2029
US$ 3,000.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global TROP2 Antibody Market & Clinical Trials Insight 2029 Report Offering:Global TROP2...
August 2024
200 pages
Brazil Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering:Brazil Clinical Trials M...
August 2024
-
Pericarditis Drugs Market - 2024-2031
US$ 3,400.00
Pericarditis Drugs Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Pericarditis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
August 2024
44 pages
Antinauseants Market - 2024-2031
US$ 3,400.00
Antinauseants Market reached US$ 2.3 billion in 2023 and is expected to reach US$ 3.7 billion by 2031, growing with a CAGR of 6.20% during the forecast period 2026-2031. The Antinauseants Market emerg...
August 2024
39 pages
Bacterial Vaginosis Drugs Market - 2024-2031
US$ 3,400.00
Bacterial Vaginosis Drugs Marketis is growing with a CAGR of 2.50% during the forecast period 2026-2035. The Bacterial Vaginosis Drugs Market emerges as a key focus in DataM Intelligence latest in-dep...
July 2024
51 pages
Antiepileptic Drugs Market - 2024-2031
US$ 3,400.00
The Antiepileptic Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
July 2024
45 pages
Anti-Diarrheal Drugs Market - 2024-2031
US$ 3,400.00
The Anti-Diarrheal Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
July 2024
46 pages
H1N1 (swine flu) Vaccination Market - 2024-2031
US$ 3,400.00
The H1N1 (swine flu) Vaccination Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
July 2024
54 pages
Amyloidosis Treatment Market - 2024-2031
US$ 3,400.00
The Amyloidosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver un...
July 2024
47 pages
Intravenous Iron Drugs Market - 2024-2031
US$ 3,400.00
Intravenous Iron Drugs Marketis is growing with a CAGR of 8.10% during the forecast period 2026-2035. The Intravenous Iron Drugs Market emerges as a key focus in DataM Intelligence latest in-depth ana...
July 2024
48 pages
Folinic Acid Market - 2024-2031
US$ 3,400.00
Folinic Acid Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Folinic Acid Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasone...
July 2024
38 pages
Beta Inosine Market - 2024-2031
US$ 3,400.00
The Beta Inosine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
July 2024
38 pages
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
US$ 2,970.00
... in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy drugs market. Based on type of drugs, the market is segmented ... the largest market share in the immunotherapy drugs market, by type of drugs in 2016. On the other hand, checkpoint inhibitors segment is expected to be the fastest growing segment in the immunotherapy drugs market, by type of drugs, in 2016 ...
July 2024
335 pages
Hepatoblastoma Market - 2024-2031
US$ 3,400.00
Hepatoblastoma Market reached USD 366.7 million in 2022 and is expected to reach USD 688.2 million by 2031, growing with a CAGR of 8.40% during the forecast period 2026-2031. The Hepatoblastoma Market...
July 2024
40 pages
Mid-Size Pharmaceutical Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription, Over the Counter), Drug Development Type (In-house and Outsource), Drug Designation Type (Orphan Drugs and Non-Orphan Drugs), Formulation (Tablets and Capsules, Injectables, Topical, and Others), Indication (Cardiovascular Diseases, Pain Management, Respiratory Diseases, Diabetes, Oncology, Infectious Diseases, Neurology, Immunology, Ophthalmology, Autoimmune, and Others), and Geography
US$ 4,450.00
According to our new research study on “Mid-Size Pharmaceutical Market Forecast to 2034 Global Analysis – by technology, application, animal type and Geography,” the market is anticipated to grow from...
July 2024
186 pages
Antifungal Drugs Market - 2024-2031
US$ 3,400.00
Antifungal Drugs Marketis is growing with a CAGR of 3.30% during the forecast period 2026-2035. The Antifungal Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
July 2024
42 pages
Bacteriophages Therapy Market - 2024-2031
US$ 3,400.00
The Bacteriophages Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
July 2024
48 pages
Drugs and Diagnostics for Hematological Disorders: Global Markets
US$ 4,650.00
This BCC Research report presents an analysis of the current state of hematological disorders and blood cancers, therapy and technology, and utilization of the various therapeutic and diagnostic modalities to prevent and treat these disorders. Forecast provided through 2020.
July 2024
133 pages
Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
US$ 2,999.00
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% du...
July 2024
146 pages
Antihyperlipidemic Drugs Market Report by Drug Class (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Stores, Online Retailers), and Region 2024-2032
US$ 2,999.00
The global antihyperlipidemic drugs market size reached US$ 12.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2032, exhibiting a growth rate (CAGR) of...
July 2024
136 pages
Cancer Immunotherapy Market Report by Therapy Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators, and Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, and Others), End User (Hospitals, Cancer Research Centers, Clinics, and Others), and Region 2024-2032
US$ 2,999.00
The global cancer immunotherapy market size reached US$ 118.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 261.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8....
July 2024
143 pages
Over The Counter (OTC) Drugs Market Report by Product Type (Cough, Cold and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Dosage Form (Tablets and Capsules, Liquids, Ointments, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032
US$ 2,999.00
The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAG...
July 2024
145 pages
Turkey Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering:Turkey Clinical Trials M...
July 2024
500 pages
Calcium Channel Blocker Market - 2024-2031
US$ 3,400.00
Calcium Channel Blocker Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035. The Calcium Channel Blocker Market emerges as a key focus in DataM Intelligence latest in-depth a...
July 2024
49 pages
Hemorrhoid Treatment Devices Market - 2024-2031
US$ 3,400.00
The Hemorrhoid Treatment Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
June 2024
54 pages
Interferons Market - 2024-2031
US$ 3,400.00
The Interferons Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
June 2024
37 pages
Dravet Syndrome Therapeutics Market - 2024-2031
US$ 3,400.00
Dravet Syndrome Therapeutics Marketis is growing with a CAGR of 11.50% during the forecast period 2026-2035. The Dravet Syndrome Therapeutics Market emerges as a key focus in DataM Intelligence lates...
June 2024
55 pages
Malaria Vaccines Market - 2024-2031
US$ 3,400.00
Malaria Vaccines Marketis is growing with a CAGR of 31.85% during the forecast period 2026-2035. The Malaria Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wher...
June 2024
42 pages
